news Scmp World 2026-09-16

GSK acquires rights to Chinese cancer drug in $750 million deal

Pharmaceutical giant GSK has purchased global rights for a new cancer therapy from Chinese firm Chimagen Biosciences.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10